These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2186773)
1. Insulin-tumour interrelationship in EL4 lymphoma or thymoma-bearing mice. I. Alloxan-diabetic or non-diabetic mice. Yam D; Zilberstein A; Fink A; Nir I Br J Cancer; 1990 May; 61(5):689-94. PubMed ID: 2186773 [TBL] [Abstract][Full Text] [Related]
2. Insulin-tumour interrelationships in EL4-lymphoma or thymoma-bearing mice. II. Effects of dietary omega-3 and omega-6 polyunsaturated fatty acids. Yam D; Fink A; Nir I; Budowski P Br J Cancer; 1990 Dec; 62(6):897-902. PubMed ID: 2124137 [TBL] [Abstract][Full Text] [Related]
3. Growth of a thymoma in diabetic mice treated with insulin. Pavelić K; Slijepcević M Eur J Cancer (1965); 1978 Jun; 14(6):675-9. PubMed ID: 658091 [No Abstract] [Full Text] [Related]
4. Effect of thymidine on the survival of mice with EL4 tumors. Reiter H Cancer Res; 1979 Dec; 39(12):4856-60. PubMed ID: 498113 [No Abstract] [Full Text] [Related]
5. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy. Won J; Kim H; Park EJ; Hong Y; Kim SJ; Yun Y Cancer Res; 1999 Mar; 59(6):1273-7. PubMed ID: 10096559 [TBL] [Abstract][Full Text] [Related]
6. Insulin-tumour interrelationships in thymoma bearing mice. Effects of dietary glucose and fructose. Yam D; Fink A; Nir I; Budowski P Br J Cancer; 1991 Dec; 64(6):1043-6. PubMed ID: 1764366 [TBL] [Abstract][Full Text] [Related]
7. Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines. Salem ML Int Immunopharmacol; 2005 Jun; 5(6):947-60. PubMed ID: 15829411 [TBL] [Abstract][Full Text] [Related]
8. 57Co-bleomycin kinetics in normal and tumour-bearing mice after systemic and local administration. Bier J; Benders P; Bitter K; Wenzel M J Maxillofac Surg; 1979 Feb; 7(1):32-40. PubMed ID: 86593 [TBL] [Abstract][Full Text] [Related]
9. Habituation of a mammary aplastic carcinoma on diabetic conditions. Pavelić K; Basić I; Pavelić J J Cancer Res Clin Oncol; 1980; 97(3):275-83. PubMed ID: 7002934 [TBL] [Abstract][Full Text] [Related]
10. Vitis vinifera L. grape skin extract activates the insulin-signalling cascade and reduces hyperglycaemia in alloxan-induced diabetic mice. Soares de Moura R; da Costa GF; Moreira AS; Queiroz EF; Moreira DD; Garcia-Souza EP; Resende AC; Moura AS; Teixeira MT J Pharm Pharmacol; 2012 Feb; 64(2):268-76. PubMed ID: 22221103 [TBL] [Abstract][Full Text] [Related]
11. [Alloxan induced long term diabetes in the domestic pig. I]. Emmrich P; Schade J; von Lengerken G; Heilmann W; Penndorf H; Hennebach H Endokrinologie; 1982 Oct; 80(2):220-30. PubMed ID: 6761106 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the hepatic response to glucagon: role of insulin, growth hormone and cortisol. Dunbar JC; Schultz S; Houser F; Walker J Horm Res; 1989; 31(5-6):244-9. PubMed ID: 2693309 [TBL] [Abstract][Full Text] [Related]
13. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790 [TBL] [Abstract][Full Text] [Related]
14. [Studies on hypoglycemic effect of extract of Balaophora polyandra in mice]. Tian JY; Ji TF; Su YL; Cong WN; Liu ZL; Ye F Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(12):1194-8. PubMed ID: 17802886 [TBL] [Abstract][Full Text] [Related]
15. [Hypoglyceminc effect of flavonoids from Prinsepia utilis on alloxan-induced diabetic mice]. Jia RY; Yin ZQ; Wu XL; Liu DB; Du YH; Luo LY; Li C; Xiong Y Zhong Yao Cai; 2008 Mar; 31(3):399-403. PubMed ID: 18619247 [TBL] [Abstract][Full Text] [Related]
16. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase. Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440 [TBL] [Abstract][Full Text] [Related]
18. [Establishment of EL4 tumor-bearing mouse models and investigation on immunological mechanisms of anti-tumor effect of melphalan]. Li ML; Li CG; Shu XH; Jia YJ; Qin ZH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):235-8. PubMed ID: 16507262 [TBL] [Abstract][Full Text] [Related]
19. Circadian eating and drinking habits in alloxan diabetic rats. Reuterving CO; Hägg E Diabete Metab; 1987 Apr; 13(2):99-105. PubMed ID: 3297838 [TBL] [Abstract][Full Text] [Related]
20. Improvement of macrophage dysfunction by administration of anti-transforming growth factor-beta antibody in EL4-bearing hosts. Maeda H; Tsuru S; Shiraishi A Jpn J Cancer Res; 1994 Nov; 85(11):1137-43. PubMed ID: 7829399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]